EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension

Nicholas A Kolaitis, Christopher F Barnett, Kelly M Chin, Katharine Clapham, Michael A Incze, Amy J Kennedy, John F Kingrey, Yuri Matusov, Lana Melendres-Groves, Franz P Rischard, Marc A Simon

CHEST · 2026-08 · 170 (2) · 524-537

DOI: 10.1016/j.chest.2026.02.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CHEST, 2026-08. Verfasst von Nicholas A Kolaitis und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco, San Francisco, CA. Electronic address: nicholas.kolaitis@ucsf.edu. Hauptthemen laut MEDLINE: Methamphetamine, Hypertension, Pulmonary, Central Nervous System Stimulants, Amphetamine-Related Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methamphetamine is a potent central nervous system stimulant that is highly addictive. Although methamphetamine use has historically been localized to the Western United States Census region, its reach has been growing, and methamphetamine use is now expanding throughout the United States and the world. Methamphetamine is now considered a definite cause of pulmonary arterial hypertension. Despite being one of the fastest growing causes of pulmonary arterial hypertension, recommendations to guide the care of patients with methamphetamine-associated pulmonary arterial hypertension have not been published. This review focuses on the care of patients with methamphetamine-associated pulmonary arterial hypertension. It provides a practical approach to care which incorporates pharmacologic therapy in conjunction with harm reduction strategies as well as support from ancillary services such as addiction medicine and social work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethamphetamineHypertension, PulmonaryCentral Nervous System StimulantsAmphetamine-Related DisordersHumans

Stichwörter der Autor:innen

PAHamphetaminemethmeth-APAHmethamphetaminepulmonary arterial hypertension

Substanzen

MethamphetamineCentral Nervous System Stimulants

Autor:innen und Institutionen

  • University of California, San Francisco, San Francisco, CA. Electronic address: nicholas.kolaitis@ucsf.edu.
  • University of California, San Francisco, San Francisco, CA.
  • University of Texas Southwestern Medical Center, Dallas, TX.
  • University of Utah, Salt Lake City, UT.
  • University of Washington, Seattle, WA.
  • INTEGRIS Health, Oklahoma City, OK.

Zitieren

APA

Kolaitis, N. A., Barnett, C. F., Chin, K. M., Clapham, K., Incze, M. A., Kennedy, A. J., Kingrey, J. F., Matusov, Y., Melendres-Groves, L., Rischard, F. P., & Simon, M. A. (2026). How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension. CHEST, 170(2), 524-537. https://doi.org/10.1016/j.chest.2026.02.016

Vancouver

Kolaitis NA, Barnett CF, Chin KM, Clapham K, Incze MA, Kennedy AJ, et al. How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension. CHEST. 2026;170(2):524-537. doi:10.1016/j.chest.2026.02.016

BibTeX
@article{Kolaitis2026,
  author = {Kolaitis, Nicholas A and Barnett, Christopher F and Chin, Kelly M and Clapham, Katharine and Incze, Michael A and Kennedy, Amy J and Kingrey, John F and Matusov, Yuri and Melendres-Groves, Lana and Rischard, Franz P and Simon, Marc A},
  title = {How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension},
  journal = {CHEST},
  year = {2026},
  volume = {170},
  number = {2},
  pages = {524--537},
  doi = {10.1016/j.chest.2026.02.016}
}
Kostenlos starten →